MTHFR rs4846049: What Your Genotype Means
The rs4846049 single nucleotide polymorphism is a regulatory variant located in the 3' untranslated region of the human MTHFR gene. It has been investigated for its potential role in altering microRNA binding and modulating MTHFR messenger RNA expression. In candidate gene studies, rs4846049 has been tentatively associated with folate metabolism, plasma homocysteine dynamics, and susceptibility to conditions like cardiovascular disease and migraine.
What each genotype means
Typical enzyme baseline
You carry two copies of the common T allele for this regulatory variant in the MTHFR 3' untranslated region. In population studies, this genotype reflects typical baseline expression levels for this specific locus and is not associated with the regulatory alterations observed with the G allele. Evidence regarding standalone clinical effects remains limited, and cardiovascular or folate markers are influenced by overall diet and broader genetic context.
Found in approximately 35% to 50% of individuals across global populations, being most common in East Asian and European ancestries.
Intermediate regulatory effect
You carry one copy of the minor G allele alongside one copy of the T allele. Research suggests this noncoding variant may exert subtle regulatory effects on MTHFR expression, though findings regarding direct impacts on plasma homocysteine or vascular risk remain mixed and modest in effect size. Because scientific evidence is limited, this result alone does not indicate significant dysfunction in folate metabolism.
Carried by approximately 40% to 50% of individuals in most global populations.
Altered regulatory expression
You carry two copies of the minor G allele at this MTHFR regulatory locus. Some published observational studies have reported modest statistical associations between this genotype and altered MTHFR expression or minor shifts in cardiovascular markers, but evidence remains limited and conflicting across diverse cohorts. This variant does not provide a definitive assessment of your methylation status, and standard clinical guidelines do not recommend management changes based on this single marker alone.
Carried by roughly 10% to 15% of individuals worldwide, depending on ancestry.
Genomic Location and Molecular Mechanism
The single nucleotide polymorphism rs4846049 is situated on chromosome 1 within the 3' untranslated region (3' UTR) of the MTHFR gene. Rather than altering an amino acid in the protein sequence like missense mutations do, this variant occurs in a regulatory segment of the messenger RNA (mRNA). Molecular studies suggest that alleles at this locus can influence the binding affinity of small non-coding regulatory RNAs, such as microRNA-149 and microRNA-555. These microRNAs normally bind mRNA transcripts to regulate their stability or inhibit protein translation. When a nucleotide change occurs at rs4846049, it may alter how effectively these regulatory molecules repress MTHFR mRNA expression, leading to subtle variations in baseline enzyme abundance in tissues.
The Role of the MTHFR Enzyme in Folate Metabolism
The MTHFR gene provides instructions for producing the enzyme methylenetetrahydrofolate reductase. This enzyme plays a central role in the one-carbon metabolic pathway by converting 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate. This conversion step is critical because 5-methyltetrahydrofolate donates a methyl group necessary for remethylating homocysteine into the essential amino acid methionine. Methionine is subsequently used to produce S-adenosylmethionine (SAM), the universal methyl donor involved in DNA methylation, neurotransmitter synthesis, and cellular repair. Any genetic alteration that significantly impairs MTHFR function or expression can disrupt this equilibrium, occasionally leading to elevated plasma homocysteine or altered cellular folate distribution.
Current Research and Strength of Evidence
Scientific evidence linking rs4846049 to distinct clinical outcomes remains limited and consists largely of candidate gene association studies. Some research teams have reported associations between the variant and complex conditions, including coronary heart disease, migraine vulnerability, and attention-related traits in specific cohorts. Additionally, rs4846049 often exhibits moderate to high linkage disequilibrium with the more heavily studied missense variant rs1801131 (A1298C), meaning that it is frequently inherited alongside other functional polymorphisms. However, large-scale genome-wide association studies (GWAS) have not universally replicated these candidate associations. Because available findings stem from modest sample sizes across select ancestral populations, these associations must be viewed as preliminary rather than diagnostic markers.
Interpreting Results in Everyday Health
Carrying a specific genotype at rs4846049 does not mean you have a disease or a definitive metabolic disorder. Major public health organizations, including the Centers for Disease Control and Prevention (CDC), emphasize that standard dietary folate intake is far more influential in determining active blood folate levels than single common MTHFR variants. Standard recommendations for balanced nutrition, dietary folate, and folic acid supplementation remain protective regardless of your MTHFR genotypes. This genetic information should never be used to initiate self-directed mega-dose supplementation or alter prescribed treatments. Any questions regarding vitamin status, homocysteine screening, or cardiovascular wellness should be discussed directly with a qualified healthcare professional.
How common is this variant?
The minor allele (G) occurs at a frequency of approximately 0.30 to 0.40 across global populations, with heterozygous and homozygous genotypes commonly observed across diverse ancestral cohorts.
Frequently asked questions
Does having rs4846049 mean I have an MTHFR deficiency?
No, carrying a variant allele at rs4846049 does not mean you have severe MTHFR deficiency. Clinical MTHFR deficiency is an extremely rare metabolic condition caused by damaging mutations, whereas rs4846049 is a common regulatory polymorphism with mild, often subtle, physiological effects.
Can I still take folic acid if I carry the rs4846049 G allele?
Yes. Public health authorities, including the CDC, confirm that individuals with common MTHFR gene variants are fully capable of processing all forms of folate, including folic acid. Getting sufficient dietary folate remains the primary determinant of optimal folate levels.
Is rs4846049 the same as the MTHFR C677T variant?
No, they are distinct genetic variants located in different regions of the MTHFR gene. While C677T (rs1801133) alters the coding sequence of the enzyme, rs4846049 is located in the non-coding 3' untranslated region, influencing gene regulation rather than amino acid composition.
Should I change my medication or supplement routine based on this variant?
You should not adjust medications, discontinue treatments, or start high-dose supplements based on this genotype alone. Clinical guidelines do not recommend altering therapy for rs4846049, so any concerns should be evaluated alongside conventional blood work by your doctor.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4846049?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Functional polymorphism influencing homocysteine dynamics and vascular endothelial recovery during high-intensity training.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The C677T variant in the MTHFR gene is associated with reduced enzyme activity and mild hyperhomocysteinemia, particularly in individuals with low folate intake.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.